Source: Annual Congress 2004 - Cardio-vascular function in OSA patients
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
I. M. Bardakci, H. Firat, Z. Dansuk, C. P. Tastan Dursun, P. Alagoz, Z. Yildirim, S. Ardic (Ankara, Turkey). Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome. Eur Respir J 2004; 24: Suppl. 48, 3479

Member's Comments

No comment yet.

Related content which might interest you: Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004 Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005 CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004 Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007 Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004 Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Endothelial function in obstructive sleep apnea syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009 BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Circulating survivin levels in patients with obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005 Decreased circulating endothelial progenitor cells in obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Plasma orexin-A levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004 Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020 Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 Plasma levels of vascular endothelial growth factor in children with sleep-disordered breathing Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005 Endothelial dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011